By Debdeep Gupta | 11 Jun, 2026
Lenskart shares in focus as 2.3% equity worth Rs 1,960 crore changes hands in block deal
Shares of Lenskart Solutions Ltd were in focus on Thursday after 4 crore shares, representing about 2.3 percent equity, were sold in a block deal valued at about Rs 1,960 crore. The transaction was executed at Rs 490 per share, representing a discount of about 2.1 percent to the previous closing price.While the buyers and sellers were not immediately known, CNBC-TV18 had reported on Wednesday that...
Live Comments
Arvind01 2025-06-19 15:09:06
A pharmaceutical company announced that a recent inspection by the U.S. Food and Drug Administration (FDA) at its oncology injectable facility in Ahmedabad ended with two observations, neither of which relate to data integrity.
Login & Reply Like(0) Dislike(0) Repost SpamProfitGainer01 2025-03-19 11:10:57
Pharma company gets USFDA nod for 60mg Apalutamide tablets, used for prostate cancer. The drug had $1.1B in US sales.
Login & Reply Like(0) Dislike(0) Repost SpamArvind01 2025-02-27 09:22:43
The company introduced India's first flu protection quadrivalent influenza virus vaccine, VaxiFlu-4, offering seasonal protection against four new virus strains. The vaccine has been cleared by the Central Drug Laboratory (CDL) and aims to address the public health challenge posed by seasonal influenza outbreaks.
Login & Reply Like(0) Dislike(0) Repost SpamArvind01 2025-02-17 11:27:38
Zydus Lifesciences announced the successful completion of a US FDA surveillance inspection at its API (active pharmaceutical ingredient) manufacturing facility in Ambernath, Maharashtra. The inspection, conducted from February 10 to 14, 2025, concluded with no observations.
Login & Reply Like(0) Dislike(0) Repost Spam